Qualigen Therapeutics, Inc.
QLGN
Revenue
1.63M
▲19.86k▲1.24%
3 Months ChangeAssets
534.41k
▼-468.80k▼-46.73%
3 Months ChangeLiabilities
4.14M
▼-1.82M▼-30.55%
3 Months ChangeFree Cash Flow
-2.83M
▲1.10M▲27.96%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001493152-24-043352
2024-10-29
Form 8-K
ID: 0001493152-24-042874
2024-10-22
Form 8-K
ID: 0001493152-24-042068
2024-10-09
Form 8-K
ID: 0001493152-24-040599
2024-09-26
Form 8-K
ID: 0001493152-24-038351
2024-09-20
Form 8-K
ID: 0001493152-24-037600
2024-09-09
Form 8-K
ID: 0001493152-24-035508
2024-09-05
Form 8-K
ID: 0001493152-24-035102
2024-08-14
Form 10-Q
ID: 0001493152-24-032161
2024-08-05
Form 8-K
ID: 0001493152-24-030244